Home/Filings/4/0001127602-23-022931
4//SEC Filing

BLAISE LUCILE 4

Accession 0001127602-23-022931

CIK 0000943819other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 1:08 PM ET

Size

6.4 KB

Accession

0001127602-23-022931

Insider Transaction Report

Form 4
Period: 2023-08-17
BLAISE LUCILE
President, Sleep & RC Business
Transactions
  • Award

    ResMed Common Stock

    2023-08-17+8197,441 total
  • Award

    ResMed Common Stock

    2023-08-17+3,29410,735 total
Footnotes (2)
  • [F1]Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
  • [F2]Represents performance-based restricted stock units granted on July 1, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001938112

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 1:08 PM ET
Size
6.4 KB